Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
NDA
.
Show all posts
Showing posts with label
NDA
.
Show all posts
Monday, August 10, 2026
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara) Brain Cancer Imaging Candidate
›
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) announced the resubmission of a New Drug Application (NDA) to the United Stat...
Monday, July 20, 2026
Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate (tiratricol) for MCT8 Deficiency
›
Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (NASDAQ Stockholm: EGTX), today announced that the U.S. Food and Drug Administrati...
Wednesday, December 22, 2021
Submission of HTX-019 (aprepitant) NDA for the Prevention of Postoperative Nausea and Vomiting to FDA
›
Heron Therapeutics, Inc. announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...
›
Home
View web version
